This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Envision Healthcare Holdings, Inc. (NYSE: EVHC) (the “Company”) announced today that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed secondary offering of 27.5 million shares of its common stock by certain stockholders of the Company. Investment funds sponsored by, or affiliated with, Clayton, Dubilier & Rice, LLC and certain executive officers and employees of the Company will be the selling stockholders. In connection with the offering, the selling stockholders will grant the underwriters an option to purchase up to 4.125 million additional shares of common stock. The Company will not receive any proceeds from the proposed secondary offering. The proposed secondary offering will be made only by means of a prospectus.
Goldman, Sachs & Co., Barclays, BofA Merrill Lynch and Citigroup are serving as lead joint book-running managers and as representatives of the underwriters for the proposed secondary offering.
When available, copies of the preliminary prospectus relating to the proposed secondary offering may be obtained from Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, New York 10282, or by telephone at 1-866-471-2526, or by facsimile at 1-212-902-9316 or by email at
email@example.com; Barclays, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (888) 603-5847, or by e-mail:
firstname.lastname@example.org; BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department, email
email@example.com; or Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (800) 831-9146, or by e-mail:
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state.